CIK 0000949858 · Non-accelerated filer<br>Smaller reporting company
ACHIEVE LIFE SCIENCES, INC.
Sign in to watch- Ticker
- ACHV
- Exchange
- Nasdaq
- Industry
- In Vitro & In Vivo Diagnostic Substances
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 954343413
- Phone
- 425-686-1500
- Business address
- 22722 29TH DR. SE, SUITE 100, SEATTLE, WA, 98021
- Former names
- ONCOGENEX PHARMACEUTICALS, INC., SONUS PHARMACEUTICALS INC
- 4/A Open-market sale EVP, CMO sold 1,364 shares at $8.68 ($11,840)
- 4/A Open-market sale EVP, CMO sold 534 shares at $11.90 ($6,355)
- 4/A Open-market sale President and CEO sold 3,112 shares at $8.68 ($27,012)
- 4/A Open-market sale President and CEO sold 2,134 shares at $11.90 ($25,395)
- 4/A Open-market sale PAO sold 385 shares at an average $8.86 ($3,411)
- 4 Shares withheld for taxes PAO gave up 372 shares (to pay taxes)
- 4 Shares withheld for taxes President and CEO gave up 2,951 shares (to pay taxes)
- 4 Shares withheld for taxes EVP, CMO gave up 1,293 shares (to pay taxes)
- S-8 Other Securities Offered to Employees in Benefit Plans
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
- 4 Derivatives Options or other derivatives
- 424B5 Offering Prospectus
- 8-K Event Material agreement
- SC 13G/A Stake Amended Statement of Ownership
- 8-K Event Bylaws or fiscal year change · Shareholder vote results
- 4 Option exercise Director acquired 2,000 shares (option exercise)
- 4 Option exercise Director acquired 2,000 shares (option exercise)
- 4 Option exercise Director acquired 2,000 shares (option exercise)
- 4 Option exercise Director acquired 2,000 shares (option exercise)
Page 39 of 68 · 1,358 filings